Ajanta Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ajanta Pharma Limited has submitted a compliance certificate for the quarter ended 31st March 2026, as required under SEBI regulations. The certificate from the company's Registrar and Share Transfer Agent, MUFG Intime India Private Limited, confirms that all securities received for dematerialization during the quarter were properly processed and confirmed to the depositories. The filing also confirms that physical share certificates were mutilated and cancelled after verification, and depositories were substituted in the register of members within the prescribed timelines.
This is a routine regulatory compliance filing confirming proper handling of share dematerialization. There is no direct impact on shareholders or stock price as this only validates that standard share registry procedures are being followed correctly.